Human genetics und molecular Diagnostics: Innovative solutions constantly changing requirements
As the rapid pace of development in human genetics and molecular diagnostics continues unabated, it's worth asking whether traditional laboratory information systems (LIS) are still capable of meeting current requirements in these fields
20 January 2022
Looking back, moving forward
Richard Craven, chief executive of CliniSys, reviews 2021 and considers how the ongoing impact of Covid-19 and the rapid formation of pathology networks will impact the company in 2022. He also pauses to unwrap a ‘Christmas present’; the VUE diagnostic console that enables clinicians to report and view test results alongside many other sources of patient information.
9 December 2021
LabPinnacle 2 – Beyond LIMS: The Value of Coordinated Orders and Results Management
The Value of Coordinated Orders and Results Management for Outreach & Ambulatory Laboratory Testing. Extending lab reach beyond hospital walls works best with the integration of specialized surrounding solutions.
11 October 2021
Introducing GLIMS Genetics Counselling
In 2019, CliniSys | MIPS launched its Genetics LIS, with a successful phase of development and deployment in Europe. Now, it has launched a clinical counterpart to the system. Stéphane Decap and Emma Huntridge outline the benefits of GLIMS Genetics Counselling to clinicians, laboratories, patients and their families.
28 September 2021
New look, same values, renewed commitment to innovation
CliniSys Group has created a single brand for the UK and Europe, with a new website, colour palette and logo. What does it all mean for us, our customers and business partners? Michael Simpson, Group Chief Executive Officer explains. Hello and welcome to the new CliniSys | MIPS website! A single name brand for CliniSys […]
18 March 2021
Day in the life – Richard Mertens
We caught up with one of our GLIMS Project Managers, Richard Mertens, to find out more about his work at CliniSys | MIPS and what he most enjoys about his role.
2 March 2021
Day in the life – Dominick Deman
Find out why Dominick Deman joined CliniSys | MIPS and what he loves about his job as GLIMS Software Developer.
27 February 2021
MIPS makes an important contribution to the fight against corona in Belgium, the Netherlands, France and Germany
In an effort to control the COVID-19 pandemic and to significantly scale up testing capacity, governments throughout the world have set up screening programmes. In Belgium, the Netherlands, France and Germany, the software systems from MIPS are playing an important role in these programmes by facilitating the communication between the laboratories, the governmental software platforms, and the various agencies that centralise and report on the data.
5 November 2020
What’s important in selecting a LIS for Anatomic Pathology?
If you are about to embark on finding an Anatomic Pathology (AP) LIS supplier, which criteria should you consider when choosing a vendor? Romaric Croes, pathologist and founder of LIS DaVinci and clinical director at MIPS, offers some recommendations.
2 October 2020
What genomic laboratory hubs can learn from pathology networks; why is the first lesson ‘implement a single LIMS?’
What can the mobilising genomics laboratory hubs learn from the more advanced pathology networks? CliniSys marketing manager Matthew Fouracre put the question to programme manager Tony Oliver and genomics consultant Steve Abbs, who agreed the first lesson would be: implement a single laboratory information system to drive standardisation.
10 May 2020
Standardisation in clinical genomic testing
One of the major drivers for forming genomic laboratory hubs is to ensure quality at scale and equitable testing, by encouraging greater standardisation. However, CliniSys genomics consultant Steve Abbs argues that hubs in themselves will struggle to achieve this, and other drivers and facilitators are needed – not least a single LIMS.
10 May 2020